Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

High Intensity Interval Training Improves Glycaemic Control and Pancreatic β Cell Function of Type 2 Diabetes Patients


Physical activity improves the regulation of glucose homeostasis in both type 2 diabetes (T2D) patients and healthy individuals, but the effect on pancreatic β cell function is unknown. We investigated glycaemic control, pancreatic function and total fat mass before and after 8 weeks of low volume high intensity interval training (HIIT) on cycle ergometer in T2D patients and matched healthy control individuals. Study design/method: Elderly (56 yrs±2), non-active T2D patients (n = 10) and matched (52 yrs±2) healthy controls (CON) (n = 13) exercised 3 times (10×60 sec. HIIT) a week over an 8 week period on a cycle ergometer. Participants underwent a 2-hour oral glucose tolerance test (OGTT). On a separate day, resting blood pressure measurement was conducted followed by an incremental maximal oxygen uptake (O2max) cycle ergometer test. Finally, a whole body dual X-ray absorptiometry (DXA) was performed. After 8 weeks of training, the same measurements were performed. Results: in the T2D-group, glycaemic control as determined by average fasting venous glucose concentration (p = 0.01), end point 2-hour OGTT (p = 0.04) and glycosylated haemoglobin (p = 0.04) were significantly reduced. Pancreatic homeostasis as determined by homeostatic model assessment of insulin resistance (HOMA-IR) and HOMA β cell function (HOMA-%β) were both significantly ameliorated (p = 0.03 and p = 0.03, respectively). Whole body insulin sensitivity as determined by the disposition index (DI) was significantly increased (p = 0.03). During OGTT, the glucose continuum was significantly reduced at -15 (p = 0.03), 30 (p = 0.03) and 120 min (p = 0.03) and at -10 (p = 0.003) and 0 min (p = 0.003) with an additional improvement (p = 0.03) of its 1st phase (30 min) area under curve (AUC). Significant abdominal fat mass losses were seen in both groups (T2D: p = 0.004 and CON: p = 0.02) corresponding to a percentage change of -17.84%±5.02 and -9.66%±3.07, respectively. Conclusion: these results demonstrate that HIIT improves overall glycaemic control and pancreatic β cell function in T2D patients. Additionally, both groups experienced abdominal fat mass losses. These findings demonstrate that HIIT is a health beneficial exercise strategy in T2D patients.

Trial Registration NCT02333734


Type 2 diabetes (T2D) can be defined as a bihormonal metabolic disorder characterised by insufficient insulin secretion and abnormal glucagon secretion [1]. According to International Diabetes Federation, estimated worldwide prevalence of diabetes was 382 million people in 2013 with a projection of 592 million people suffering from diabetes in 2030. It is well established that physical activity per se improves glucose homeostasis [24], a cornerstone of regulating overall glycaemic control among T2D patients. As of 2013, it is recommended that T2D patients should perform at least 150 minutes per week of moderate-intensity aerobic exercise corresponding to 50–70% of maximal heart frequency [5,6]. Since Bjorntorp and co-workers established the importance of regular moderate to strenuous exercise to increase insulin sensitivity among T2D patients [7], considerable molecular and metabolic research has demonstrated pivotal (patho)physiological linkages between health-related benefits of physical activity and T2D. Though physical exercise is advocated in the treatment of T2D, existing strategies face huge challenges, including the lack of adherence, motivation and time to follow these guidelines [6].

Recently, more focus has addressed the health beneficial effects of different high intensity interval training (HIIT) regimens to T2D. Novel findings here include reduced hyperglycaemia following 2 weeks of HIIT on cycle ergometer [8,9], ameliorated insulin action and upregulated skeletal muscle metabolic capacity after walking intervals [10] and improved pancreatic β-cell function [11]–pivotal physiological phenomena in the attempt to regulate whole body metabolism in T2D patients. These health beneficial effects seem to be independent of changes in body weight in moderate intensity training regimens [1214], and glycaemic control may be even more improved by intensities above recommended guidelines [15,16]. There seems to be accumulating evidence that HIIT induces increased overall fat loss and abdominal fat mass loss as opposed to traditional continuous endurance training [17]. The cardiovascular adaptations that appear with HIIT are comparable, or even sometimes superior as opposed to traditional continuous endurance training [1820]. However, in the T2D population, research in long-term training-induced changes of both glycaemic control and the pancreatic homeostasis is sparse and further detailed knowledge on this topic is needed to evaluate the true clinical effect of training.

In inactive individuals diagnosed with T2D and age- and BMI-matched normal glucose tolerant subjects, we therefore tested the effects of 8 weeks of low volume HIIT on 1) Glycaemic control (fasting plasma glucose concentration, 2-hour oral glucose tolerance test (OGTT) response, area under curve (AUC) and glycosylated haemoglobin (HbA1C)), 2) pancreatic homeostasis (OGTT-derived surrogate markers) and 3) total fat and abdominal fat mass.



Subjects were recruited through local newspaper advertisements and evening sessions at Centre for Clinical Research, Vendsyssel Hospital, Aalborg University, where the study was carried out. 10 T2D patients and 13 age, height and weight matched control (CON) individuals were eligible for the study (see flow chart, Fig 1). All individuals answered a medical questionnaire to evaluate their individual lifestyles (history of genetic T2D, physical activity, smoking habits, alcohol consumption and diet). T2D inclusion criteria were: 2-hour end point OGTT ≥ 11.1 mmol·l-1, BMI < 40 kg·m-2, both genders and < 65 of age. Exclusion criteria were: diabetes duration < 1 year, BMI < 25 kg·m-2, moderate intensity exercise > 1 hour per week, use of exogenous insulin, evidence of liver, renal, cardiopulmonary, neuromuscular and/or psychological disease, other debilitating diseases or contraindicating physical activity [21]. Furthermore, there were two eligibility tests during the visits: 1) if markers or analytes as given below in detail did not fulfil criteria ranges, subjects were excluded and 2) if there were any perturbations during the heart cycle electrocardiogram (ECG) of both resting and working myocardium, subjects were excluded. All ten T2D patients were under treatment with oral antidiabetic agents, either with metformin (N = 8) or glimepiride (N = 2). Additionally, lipid-reducing agents (N = 9), anti-hypertensive agents (N = 8), glucagon-like peptide-1 (GLP-1) receptor agent (N = 1) and glucagon-like peptide-1 (GLP-1) inhibitor agent (N = 3) were taken on a daily basis. All subjects continued their medication throughout the study.

Fig 1. Flow chart.

1 T2D patient was excluded due to impossible insertion of catheter, and the last T2D patient dropped out of the study immediately after the initiation of HIIT. 5 matched controls were excluded due low BMI.

The study was approved by the Ethics committee of Central and North Denmark Region (M-2013-56-13) and implemented in accordance with the guidelines of Declaration of Helsinki. The study was registered at (NCT02333734). Written informed consent was obtained from all participants prior enrolment to the study.

Participants were carefully instructed to continue their individual eating habits and to maintain a eucaloric diet [22].

Experimental overview

Baseline post intervention outcomes were assessed over three test days in the week before and in the week following the HIIT program. On Mondays, Wednesdays and Fridays in week 1–8, participants conducted HIIT. An outline of the experimental time schedule appears in Fig 2.

Fig 2. Study overview of the experiment prior to and after the HIIT intervention.

On a separate day, a urine sample, oral glucose tolerance test (OGTT), weight and height measurements were conducted. On another day: resting blood pressure measurement in supine position and 12-lead electrocardiogram (ECG) prior and after measurement of maximal oxygen consumption on bicycle ergometer. On the last experimental day, a whole body dual energy X-ray absorptiometry (DXA) was performed. These measurements were followed by 8 weeks of HIIT. Finally, laboratory measurements were repeated.

Study design

Day 1 –oral glucose tolerance test.

All participants underwent an OGTT before (week 0) and again after the HIIT intervention (week 9). All subjects abstained from performing any strenuous physical activity for 2–3 days prior to both OGTTs to avoid the effects of acute exercise. The participants came into the clinic after a 12-hour overnight fast. Before the initiation of the OGTT, a fasting urine sample was collected from each participant and was immediately frozen and stored at -80°C. This was followed by an assessment of body weight (TANITA, BWB-800), height (only at week 0) and waist circumference in duplicate at the level of the umbilicus conducted by a trained person. Then fasting capillary blood glucose was conducted and analysed in duplicate using an OneTouch glucose monitoring apparatus (Precision Xceed MediSense, Abbott Laboratories A/S, Denmark).

Afterwards, a cannula (Beckton, Dickinson & Company, Franklin Lakes, NJ, USA) was carefully placed into an antecubital vein followed by infusion of saline solution to control and maintain clean access. Fasting venous blood samples were taken to the times -15, -10 and 0 minutes before a glucose load of 75 g anhydrous glucose dissolved in water was given. At the first (-15 min) fasting venous blood sample, 4 blood samples were taken to screen the coagulation (II, VII, X and INR), liver (ASAT and ALAT), cell (leucocytes, erythrocytes and thrombocytes), kidney (albumin and creatinine), inflammatory (CRP) and hormonal (TSH) status to preclude any underlying disease. At same time point (-15 min), additional 3 blood samples were taken to determine overall inflammation, lipids and HbA1C. At all time points (-15, -10 and 0 min), a blood sample was collected to analyse glucose, insulin and glucagon. Following the glucose load ingestion, venous blood samples were taken after 15, 30, 60 and 120 minutes and were assayed for glucose, insulin and glucagon concentrations. ~10 g of saline solution was flushed through the vein after each collected blood sample. Each blood sample was transferred to either 2.7 ml EDTA (Beckton, Dickinson & Company, Franklin Lakes, NJ, USA) or lithium heparin (Beckton, Dickinson & Company, Franklin Lakes, NJ, USA) evacuated tubes, briefly stored on ice (<30 min) and centrifuged at 4°C for 15 min at 3000 rpm to provide plasma samples. Plasma was then separated into aliquots and stored at -80°C until further analysis.

Biochemical analyses.

All analytic processes were conducted according to the manufacturer’s instructions. Plasma glucose content (unit: mmol·l-1) was determined applying an enzymatic reference method (Roche Diagnostics, Switzerland) on a Cobas c111 system. Plasma insulin concentrations (unit: pmol·l-1) were measured with an enzyme-linked immunosorbent assay (ELISA) (Dako, Glostrup, Denmark) and plasma glucagon concentrations (unit: pg·ml-1) were determined by a radioimmunoassay (RIA) kit (EMD Millipore Corporation, Billerica, MA, USA). Glycosylated haemoglobin (HbA1C) was determined applying high-performance liquid chromatography (HPLC) on the TOSOH G8 (Tosoh Bioscience, Tokyo, Japan). Health status markers, fasting total cholesterol (TC), high-density lipoprotein (HDL) and triglyceride (TG) were determined using the immunonephelometry procedure (Siemens, Erlangen, Germany) on the Vista Dimension 1500 system. Low-density lipoprotein (LDL) was estimated by using the Friedewald equation. Except for glucose, all samples were analysed in duplicate.

Day 2 –aerobic testing and blood pressure.

On a separate day, subjects performed an incremental exercise test on a cycling ergometer (Monark 928 E, Varberg, Sweden) to determine maximal pulmonary oxygen uptake (O2max). The exercise protocol began with a warm-up phase of 8 minutes at a workload of 80–100 W, inducing a working heart frequency of ~65% of the estimated maximal heart rate (Polar 625X, Kempele, Finland). A facemask was fitted covering mouth and nose. The mask was instrumented with a flowmeter and a sampling tube allowing for continuous breath-by-breath measurement of ventilation volume and expired O2 and CO2 concentrations. These data were used for calculation of O2 values (Oxycon Pro, Jaeger Gmbh, Hoechberg, Germany). After careful instruction, each subject performed the O2max test with a workload that was increased by 15 W·min-1. During the last minutes of the test, the subjects were vigorously encouraged to continue until exhaustion, and the achievement of O2max was established by standard criteria in all tests [23]. The gas analyzers and the flow were calibrated prior to each test. Individual power output used for the HIIT intervention was taken as the power output eliciting ~90% of maximal heart rate during the O2max test. The test was repeated in week 9 after the completion of the HIIT intervention.

Subjects had their resting and post-work heart function controlled by 12-lead electrocardiogram (ECG) (Mortara ELI 150, Milwaukee, WI, USA). There were no signs of ischemia or arrhythmias during rest or after the O2max test as controlled by a physician.

Prior to each O2max test, blood pressure (Microlife BP A100 Plus, Widnau, Switzerland) was registered in a supine position in a quiet room at ambient temperature. The cuff was placed around the participant’s left arm and inflated every 10 minutes (0–30 minutes). Systolic (BPs) and diastolic (BPs) were registered followed by measurement of mean arterial pressure (BPm), i.e. BPd+⅓×(BPs-BPd). The lowest values were used for comparison. There was no or little (<30 min) intra-individual variability in the time points when the parameters were assessed before and after the HIIT intervention.

Day 3.

On a separate day (week 0), a whole body dual x-ray absorptiometry (DXA) scan (XR-800 Swissray, Cooper, Surgical, USA) was conducted at Frederikshavn Hospital. Additionally, abdominal and femoral regions were assessed for fat mass and lean mass. Another DXA scan (week 9) was conducted after the completion of the HIIT intervention for comparison. A trained radiographer performed all scans.

High intensity interval training program

Subjects conducted supervised HIIT on a cycling ergometer (Kettler Axiom, Germany) three times per week over 8 weeks (every Monday, Wednesday and Friday) in three groups of five and two groups of four. During the entire intervention, a physiotherapist supervised the subjects to control that they adhered to and completed their individual power output obtained from their O2max test. Halfway through the intervention subjects had their power output increased by ~5% for the remaining period in order to maintain a sufficient relative intensity despite neural and muscular adaptations. Each training session consisted of a 5-minute warm-up (eliciting ~65% of HRmax) followed by 10×1 minute intervals each interspersed by 1 minute of recovery [9,24]. Cadence during the HIIT was ~70 RPM. During recovery, the participants were allowed to either rest or pedal with a minimum of resistance. The session was completed by a cool-down period of 5 minutes. Total time commitment was ~30 minutes per HIIT session. During each training session, the heart rate was registered from the cycling ergometer with additional reporting of rating of perceived exertion (Borg Scale). During the intervention, participants were only allowed to exercise during the HIIT sessions. However, we allowed easy gardening, walking and other daily activities.

Calculations and statistical analyses

Statistical analyses were conducted applying the STATA 13 statistical analysis system (StataCorp LP, Texas, USA), whereas the GraphPad Prism 6 statistical analysis system (GraphPad Software Inc., San Diego, CA, USA) was applied for visual presentation. In the visual presentation, mean ± S.E.M. are given. All data were tested for normality applying QQ-plots and Bland Altman Plots. After careful evaluation, all data fulfilled the criteria of being normally distributed. Student’s paired t-test was applied to test possible differences within same group before and after the HIIT intervention. Also, student’s paired t-test was applied to determine possible changes between same time points during the OGTT before (week 0) and after the HIIT intervention (week 9). AUC was calculated by the integrated trapezoid rule [25]. The insulin resistance homeostatic model assessment (HOMA-IR) was determined from fasting plasma glucose (FPG) and fasting plasma insulin (FPI) concentrations by ((FPG×FPI)/22.5). The β-cell function (HOMA-%β) was calculated by ((20×FPI)/(FPG-3.5)). Applied glucose unit: mmol·l-1, applied insulin unit: μIU·ml-1 (determined as pmol·l-1/6) [26]. Composite insulin sensitivity index (ISIcomposite) was calculated according to the formula [27]: 10.000 divided by the square root of ((FPG×FPI)×(mean FPG×mean FPI). Insulin secretion was assessed by the insulinogenic index (IGI) [28] determined from the ratio of increases of plasma insulin to glucose measured at 30 minutes expressed as: ΔI30/ΔG30, i.e. (Insulin 30 min—Insulin 0 min)/(Glucose 30 min–Glucose 0 min). The product of the ISIcomposite and the IGI, the so-called disposition index (DI), is a useful marker of pancreatic β-cell function [29]. FPG and FPI were calculated on the basis of all fasting blood samples, i.e. the mean of -15, -10 and 0 min. Applied units were the same as already given above. In all cases, p<0.05 was considered significant. In each patient category, at least 10 individuals were mandatory to be included to achieve statistical power of metabolic parameters with 80% power and with a significance level, α = 0.05.


During the 8-week HIIT intervention both T2D and CON groups showed similar high training compliance (heart rate at end HIIT bout was ~90% of maximal heart rate) and there was total adherence from both groups in all 8 weeks. Except for 1 dropout, all subjects participated in the full range of the supervised 8-week HIIT sessions without exception, which highlights the feasibility of this exercise regimen.

Glycaemic control

In the CON-group, no significance was observed in either average fasting venous glucose concentration (p = 0.17), the 2-hour OGTT levels (p = 0.58) or HbA1C (p = 0.81). Among the T2D patients, significant reductions of average fasting venous glucose concentration (p = 0.01) (p = 0.0106), HbA1C (p = 0.036) and 2-hour end OGTT levels (p = 0.035) were observed (Fig 3A, 3B and 3C).

Fig 3. The development of glycaemic control prior to and after the HIIT intervention.

In the CON-group, there were no statistical effects (p>0.05) observed on average fasting venous glucose concentration (A), HbA1C (B) or postprandial glucose concentration 2 hours after OGTT (C). However, following 8 weeks of low volume HIIT, statistical significant reductions were detected on average fasting venous glucose concentration (A), HbA1C (B) and postprandial glucose concentration 2 hours after OGTT (C) in the T2D-group (all denoted by †).

OGTT-derived indices to assess pancreatic β-cell function and insulin resistance

In the CON-group, neither HOMA-IR (p = 0.63) nor HOMA-%β (p = 0.22) was significantly changed (Figs 4 and 5, respectively). However, in the T2D-group, HOMA-IR was significantly (p = 0.03) decreased (Fig 4) and HOMA-%β was significantly (p = 0.03) increased (Fig 5). Insulin secretion as determined by the insulinogenic index and ISIcomposite remained unaltered (p>0.05) in both groups (Fig 6A and 6B). Pancreatic β-cell function as determined by DI was unaltered in the CON-group (p = 0.99), but significantly improved (p = 0.03) in the T2D-group (Fig 6C).

Fig 4. The development of HOMA-IR.

Following 8 weeks of HIIT, the HOMA-IR in the CON-group remained unchanged (p>0.05), whereas HOMA-IR was significantly reduced p = 0.035 in the T2D-group (as denoted by †).

Fig 5. The development of HOMA-%β.

Following 8 weeks of HIIT, the HOMA-%β in the CON-group remained unchanged (p>0.05), whereas HOMA-%β was significantly reduced p = 0.026 in the T2D-group (as denoted by †).

Fig 6. The development of ISIcomposite (A), Insulin secretion (B) and DI (C).

Following 8 weeks of HIIT, ISIcomposite, Insulin secretion and DI remained unchanged (p>0.05) in the CON-group. In the T2D-group, pancreatic β-cell function as determined by DI was significantly elevated (p = 0.03) (denoted by †). In both groups, neither ISIcomposite nor insulin secretion was significantly reduced (p>0.05).

The hyperbolic intra-relationships between ISIcomposite and IGI are shown in Fig 7A (CON-group) and 7B (T2D-group). Additionally, the over-all best-fit lines attained by nonlinear regression analysis (logarithmic regression) between ISIcomposite and IGI are presented in Fig 8A–8D. The overall regression line between ISIcomposite and IGI among T2D patients was y = -6.642ln(x)+34.168 (R2 = 0.44) prior the HIIT intervention (Fig 8A) and y = -4.538ln(x)+25.608 (R2 = 0.42) afterwards (Fig 8B). For the CON-group, the overall regression line was y = -7.844ln(x)+52.016 (R2 = 0.31) before HIIT (Fig 8C) and y = -3.314ln(x)+29.167 (R2 = 0.10) after HIIT (Fig 8D).

Fig 7. Insulin sensitivity (abscissa axis) and insulin secretion (y-axis) among controls (A) and among T2D diabetes patients (B).

Small dots represent values prior HIIT intervention, whereas big dots represent values after HIIT intervention. Each colour represents one individual.

Fig 8. Hyperbola fitting of insulinogenic index and composite insulin sensitivity index.

These differences between before and after HIIT can be seen from both the CON-group (A and B) and the T2D-group (C and D).

Plasma glucose, insulin and glucagon concentrations

Following 8 weeks of HIIT, fasting and postprandial plasma glucose concentration was unaltered (p>0.05 at all time points) in the CON-group (Fig 9A). Also the plasma glucose AUC was unaltered (p = 0.35) after HIIT in the CON-group (Fig 9A). The T2D-group had changed its glucose significantly at time points -15 min (p = 0.03), -10 min (p = 0.003), 0 min (p = 0.003), 30 min (p = 0.03) and 120 min (p = 0.03) (Fig 9B). In the T2D-group, the AUC was 1580±142.3 mmol·min·l-1 at baseline and 1447±130.0 mmol·min·l-1 post intervention, however this did not amount to a significant change (p = 0.098) (Fig 9B). In the CON-group, 1st phase plasma glucose AUC over 30 minutes was not significantly changed by the intervention effect (p = 0.36) (Fig 10). In the T2D group, however, there was a significant 1st phase glucose decrease from 289.9±25.4 mmol·min·l-1 to 265.3±23.9 mmol·min·l-1 (p = 0.03) corresponding to a change of 8±3% (Fig 10). In both groups, the insulin and glucagon concentrations and their 2-hours’ AUCs were not significantly changed (p>0.05) compared to baseline (Figs 11A, 11B and 12).

Fig 9. Plasma glucose levels and total AUC before and after the HIIT intervention in the CON- and T2D-group.

Following 8 weeks of HIIT, the plasma glucose levels were not significantly reduced (p>0.05 at all time points) in the CON-group (A). Total AUC in the CON-group were not significantly reduced (p>0.05) (A). In the T2D-group (B), plasma glucose concentrations were significantly lowered at time points -15 min (p = 0.03 as denoted by †), -10 min (p = 0.003 as denoted by ‡), 0 min (p = 0.003 as denoted by ‡), 30 min (p = 0.03 as denoted by †) and 120 min (p = 0.03 as denoted by †). AUC was not statistically changed (p = 0.0982) (B).

Fig 10. 1st phase AUC after 30 minutes of the plasma glucose concentration.

Following 8 weeks of HIIT, the CON-group had unaltered (p>0.05) 1st phase AUC of plasma glucose concentration, whereas the T2D-group had reduced p = 0.03 its 1st phase plasma glucose concentration (as indicated by †).

Fig 11. Plasma insulin levels before and after the HIIT intervention.

Following 8 weeks of HIIT, the fasting insulin levels were not significantly changed in the CON-group (A) and T2D-group (B) (p>0.05 at all time points). AUC in the CON-group (A) and T2D-group (B) were not significantly reduced (p>0.05).

Fig 12. Plasma glucagon levels before and after the HIIT intervention.

Following 8 weeks of HIIT, the fasting glucagon levels were not significantly changed in any group (p>0.05 at all time points). Additionally, AUC in the both groups was not significantly changed (p>0.05).

Blood pressure, exercise capacity and lipid status

Following 8 weeks of HIIT, both the CON-group and the T2D-group significantly reduced their BPs (CON: p = 0.001; T2D: p = 0.0002), BPd (CON: p = 0.0009; T2D: p<0.0001) and BPm (CON: p = 0.0002; T2D: p<0.0001) (Table 1).

Table 1. Baseline characteristics before and after 8 weeks of high intensity interval training.

Values are means ± standard error of mean (S.E.M.).

Absolute O2max changed significantly in both groups (CON: p = 0.01; T2D: p = 0.03) with a concomitant significant increase of relative O2max (CON: p = 0.004; T2D: p = 0.002). Additionally, both groups increased absolute (CON: p<0.0001; T2D: p = 0.007) and relative (CON: p<0.0001; T2D: p = 0.002) maximal power output during incremental O2max on the final examination (Table 1). Maximal heart rate decreased during incremental O2max in both groups (CON: p = 0.01; T2D: p = 0.01) (Table 1).

No effects were demonstrated on lipid status in either group. However, in the T2D-group, post measurements of triglycerides and total cholesterol were borderline significant (p = 0.06 and 0.07) compared to baseline. HDL concentration in the CON-group was nearly significant (p = 0.06) as opposed to pre exercise values (Table 1).


Abdominal fat mass changed significantly in both groups after 8 weeks of HIIT. The CON group lowered its abdominal fat mass significantly (p = 0.02) from 3.36±0.30 kg to 3.03±0.29 kg, corresponding to percentage change of -9.66±3.07% (Fig 13A). This was also confirmed with the waist circumference measurement changing significantly from 98±3 cm to 94±3 cm (p = 0.006) (Fig 13B). Among the T2D patients, abdominal fat mass was reduced significantly (p = 0.004) from 3.06±0.28 kg to 2.57±0.32 kg. This corresponded to a percentage change of -17.84±5.02% (Fig 13A). There was also a significant reduction of the waist circumference in the T2D group from 100±2 cm to 94±3 (p = 0.02) (Fig 13B). BMI was significantly reduced in both groups, thus by p = 0.0005 in the CON-group and by p = 0.003 in the T2D-group (Table 1). Lean body mass was significantly changed (p = 0.003) in the T2D-group, whereas it remained unaltered in the CON-group (p>0.05) (Table 1). Total body fat was unaltered (p>0.05) in both groups compared to baseline (Table 1).

Fig 13. Percentage change in abdominal fat mass (A) and waist circumference (B) after 8 weeks HIIT intervention.

The CON-group lowered its abdominal fat mass significantly (p = 0.02 as denoted by †) by -9.66±3.07% and the T2D-group by -17.84±5.02% (p = 0.004 as denoted by ‡). Waist circumference changed significantly in both groups by -4.04±1.20% (p = 0.006 as denoted by ‡) in the CON-group and by -5.74±2.05% (p = 0.02 as denoted by †) in the T2D-group.


Most importantly, in this non-invasive study, we have demonstrated that 8 weeks of low volume HIIT improves glycaemic control as determined by reduced average fasting venous glucose concentration, 2-hour OGTT end point concentration and HbA1C in T2D patients. Additionally, HOMA-IR and HOMA-%β were significantly improved in the T2D-group. Maybe most importantly, the DI was significantly improved. The postprandial hyperglycaemia as determined by the OGTT-values was significantly changed at 5 out of 7 time points following HIIT as well as 1st phase AUC was significantly reduced. Additionally, all participants fulfilled the HIIT intervention indicating that it could be integrated as a future exercise strategy in inactive T2D- and CON-groups. Last-mentioned indicates a pivotal finding–it magnifies de facto HIIT as being an intriguing and seemingly optimal exercise strategy in the post-modern world in which time commitment and total exercise volume are attempted to be reduced.

Pancreatic β-cell function

To the extent that the DI represents pancreatic β-cell function, we have demonstrated that 8 weeks of supervised low volume HIIT on cycle ergometer ameliorates pancreatic β-cell function significantly. Importantly, the DI, which is an acknowledged measure of pancreatic β-cell function adjusted for insulin sensitivity and which may predict the development of T2D, has been demonstrated to be augmented following exercise with different intensities. Karstoft and colleagues reported that interval walking (5 weekly sessions of 60 min over 4 months with 3 min intervals of fast ≥70% of O2max and slow walking ~40% of O2max) significantly improved DI as opposed to continuous walking in adults with T2D [10], which was reflected in increased insulin sensitivity, but still an unaltered insulin secretion. In another study that was 8 months in length, treadmill and elliptical training at regular moderate intensity (40–55% of O2peak) showed to improve DI significantly more than vigorous intensity (65–80% of O2peak) in sedentary, adipose, moderately dyslipidemic participants [11]. Interestingly, high intensity resistance training over 12 weeks with 3 sessions per week in overweight sedentary young men improved the insulinogenic index and oral disposition index [30]. In our study, DI increased in the T2D group, although neither ISIcomposite nor IGI were significantly improved. However, given the intrasubject heterogeneity in ISIcomposite and IGI following 8 weeks of HIIT (Fig 7B) and the hyperbola fitting (Fig 8C and 8D), this could indicate that the ability of the pancreas to partially compensate for a lowered insulin resistance has been improved as opposed to baseline.

It has become clear that glycaemic control seems to be more improved by HIIT as opposed to regular moderate intensity exercise [15,16,31]. In order to assess glycaemic control, insulin secretion may be a better predictor of training responsiveness of glycaemic control as opposed to insulin sensitivity [32]. Nevertheless, equivocal findings of insulin secretion have been reported [3335]. Although not extensively validated, the IGI assists to assess the level of insulin secretion [36]. Following regular exercise, individuals with a healthy functional pancreas normally have a lowered insulin secretion relative to an improvement of insulin sensitivity. However, in a dysfunctional pancreas where the β-cell function is impaired, exercise augments insulin secretion concomitantly with an improvement of insulin sensitivity [35,37,38]. Here, we show no effect of insulin secretion following 8 weeks of HIIT. Though a slight tendency to be decreased in the CON-group and increased in the T2D-group, the unaltered insulin secretion may be explained by several physiological phenomena: a feasible explanation to the observed low and unaltered insulin secretion could be the deteriorating effect of glucotoxicity that is present in T2D patients. Considerable research demonstrates that long-term exposure to glucose can reduce the function of pancreatic β-cells in vivo [39] and in vitro [40]. To our knowledge, the insulinogenic effect of long-term exercise (≥ 12 months) in a T2D population remains to be elucidated.

The mechanisms behind the improved pancreatic β-cell function to increase insulin action could be multifaceted, including perhaps an improved coordinated feedback loop between liver (decreased hepatic gluconeogenesis), muscle (attenuated insulin resistance) and pancreas (slowly wakening of β islets to secrete insulin). However, given that T2D is a disease characterised by perturbations in several organs, anti-inflammatory cytokines secreted by both adipocytes (e.g. adiponectin) and myocytes (e.g. IL-6) could be involved in the improvement of pancreatic β-cell function.

Insulin sensitivity

Research of HIIT in non-healthy populations is sparse, however growing. The broad acceptance of OGTT as a clinical procedure has resulted in a growing number of research experiments attempting to explain the mechanisms behind the pathogenesis of T2D. Although others and we make use of OGTT-derived surrogate indices from which we must make careful interpretations, these indices still provide us with pivotal and detailed information that can have significant influence on the future treatment and research of T2D and especially the lives of these patients. Normally, regularly performed exercise lowers basal insulin levels and attenuates the insulin response to glucose load [4144] suggesting that peripheral insulin sensitivity is increased.

T2D is associated with combined impaired pancreatic endocrine function and insulin sensitivity. Exercise has proven particularly beneficial as to modifying the risk of developing T2D [21]. In the T2D population, the importance of regular exercise in relation to insulin sensitivity in existing research is surprisingly equivocal. In some studies, both regular moderate intensity exercise [4548] and HIIT [10,49,50] have shown to improve insulin sensitivity. However, few research has however demonstrated that insulin sensitivity remained unaltered following HIIT [33] and moderate intensity exercise [33,35,46]In addition, there are multiple studies finding improved insulin sensitivity among sedentary non-diabetic subjects [24,41,51]An intriguing study demonstrated that 7 consecutive days of exercise at 60–75% of heart frequency reserve improved ISIcomposite with additional improvement of AUC in a T2D population [45]. In our study, ISIcomposite was unchanged in both groups (Fig 6A). Exercise responsiveness of insulin sensitivity is based on multiple OGTT-derived indices potentially reflecting different information outcomes. In the absence of hypersinsulinemic euglycemic glucose clamp to measure insulin sensitivity directly, whole-body insulin sensitivity ISIcomposite [33], peripheral insulin sensitivity as determined by the Cederholm index [43] and even hepatic insulin sensitivity [24] indices are applied to elucidate any potential changes. However, though these indices correlate nicely with the hypersinsulinemic euglycemic glucose clamp, it is nearly impossible to unequivocally conclude the actual physiological in vivo insulin sensitivity change. Additionally, metformin, a commonly prescribed oral hypoglycemic agent, could interact with exercise impairing insulin sensitivity outcomes [52]

HOMA-IR and HOMA-%β represent pivotal indices of tissue insulin resistance and pancreatic function. Both HOMA-IR (Fig 4) and HOMA-%β (Fig 5) were significantly improved in the T2D group after the intervention. These findings are in agreement with other findings, however the results should be interpreted carefully. In a study, HOMA was improved in T2D patients following 6 months of aerobic exercise [53]. Moreover, a single extended bout of ~200 sec. of very HIIT in sedentary overweight men demonstrated a reduced HOMA-IR [41]In a Nordic study [54], 4 months of unsupervised walking did not have any impact on HOMA-IR among T2D patients. No training induced change in insulin sensitivity was found in obese women following 6 weeks of HIIT [55], although HIIT favourably altered body composition and specific skeletal muscle oxidative capacities were improved. However, others have found that >2.5 hours of weekly endurance exercise improved the composite insulin sensitivity index among overweight sedentary adults [51], although neither exercise type, exercise intensity nor age emerge from the results. Our findings in the T2D-group demonstrate that the attenuated insulin resistance may be dependent on exercise intensity as considerable research in traditional moderate intensity training does not alter insulin resistance significantly.

Glycaemic control: 2-hour OGTT, fasting plasma glucose, AUC and HbA1C

Two hours after the initiation of OGTT, glucose levels lowered significantly from 15.34±1.76 mmol·l-1 to 13.41±1.59 mmol·l-1 after 8 weeks of HIIT (Fig 3C). Additional significant findings included fasting venous blood glucose concentrations (Fig 3A) and significant lowered 1st phase AUC of glucose (Fig 10) in the T2D group. Finally, the significant decrease in HbA1C in the T2D-group demonstrated a clinical importance (Fig 3B). Our findings are in agreement with other studies. Eriksen and colleagues demonstrated a 7.5% decrease in the 2-hour AUCglucose, although the 3-hour AUCglucose was unaltered [33]. In the same study AUCinsulin was not altered [33] and neither was it in a group of sedentary overweight adults after 2 weeks of three weekly sessions of 4–6 30 s all-out exercise bouts [42]. Moreover, a single extended bout of ~200 sec. of very HIIT in sedentary overweight men demonstrated no significant effect on [41]. Following 2 weekly sessions of 10×6 sec. sprints interspersed by 1-minute recovery between each sprints over 8 weeks, AUCglucose in obese subjects was significantly reduced [56]. Among a pre-diabetic population, both a HIIT and a moderate intensity exercise session improved late-phase AUC insulin and glucose responses to an OGTT compared with a non-exercising group [57]. In our study, the tended significant increase (p = 0.087) of insulin in the T2D group may be explained by a vaguely ameliorated ability of the pancreas to waken the insulin producing β-cells for tissue action, however without a compensatory decrease of the hyperglucagonemia.

Regarding HbA1C, our findings are in agreement with other studies [5860]Interestingly, the ameliorated effect of HbA1C may even be favoured solely by resistance training [61]or a combination of aerobic exercise and resistance training [62,63]. However, data are not consistent as other research has found no beneficial effect of exercise to HbA1C [33,64].

Exercise capacity and blood pressure

Low volume HIIT interventions have become popular, assumingly due to its rapid physiological remodelling capabilities. Two studies have demonstrated that even as little as 3 weekly HIIT sessions over 2 weeks markedly can improve exercise capacity and tolerability in T2D populations [8,9], sedentary obese non-diabetic participants [42] and healthy participants [6568] as well as after 4 weeks in trained athletes [69,70]Our study demonstrated noticeable HIIT-induced improvements of absolute and relative maximal oxygen consumption. Additionally, we also observed that maximal power output during the incremental O2max test was augmented in both groups with a concomitant lowered maximal heart rate compared with baseline (Table 1). The lowered maximal heart rate is somewhat surprising, however it could be explained by a compensatory adaptation of central hemodynamics [71]

T2D is linked to endothelial dysfunction and hypertension [46]. We have demonstrated significant effects on overall blood pressure following 8 weeks of HIIT (Table 1), which may be of pivotal clinical relevance [72].


Generally, there was an overall lack of metabolic changes in the CON-group as assessed by HOMA-IR (p>0.05), HOMA-%β (p>0.05), ISIcomposite (p>0.05), IGI (p>0.05) and DI (p>0.05) indices. Both plasma glucose and insulin concentrations were lowered following the HIIT intervention, however not significantly (p>0.05). Given the solid evidence that regular exercise per se improves glycaemic control through a broad variety of physiological adaptations, our findings are both astonishing and contradictory to other research results [10]. This discrepancy could be a result from the relatively short training duration, however it is a doubtful reasoning considering the tolerability and efficacy achieved in similar interventions [41,42]. Additionally, absolute (p<0.05) and relative (p<0.01) maximal pulmonary oxygen consumption were significantly enhanced. Given the non-invasive nature of this study, a careful cause, however, could be attributable to the relatively transient improvements in insulin action that gradually vanishes after ceased exercise stimulus as demonstrated in overweight sedentary men [42]. No training induced change in insulin sensitivity was found in obese women following 6 weeks of HIIT [55], although HIIT favourably altered body composition and specific skeletal muscle oxidative capacities were improved. However, others have found that >2.5 hours of weekly endurance exercise improved the composite insulin sensitivity index among overweight sedentary adults [51], although neither type, intensity nor age emerge from the results. This indicates that there may be an early metabolic remodelling mechanism that is present in the early (≤ 24 hours) post exercise phase followed by a ‘late’ (≥ 24 hours) phase that could be characterised by not being prone to same metabolic-muscular sensitivity. It could however also be explained by the fact that the CON-group may not improve its health status markedly more.

Abdominal fat

The 8-week HIIT period lowered significantly the abdominal fat and waist circumference in both groups (Fig 13A and 13B). Noteworthy however, DXA-scans are limited in terms of distinguishing between subcutaneous and intra-abdominal fat stores. Similar findings have been demonstrated by Boudou and co-workers [73]who applied 8 weeks of combined steady state exercise (75% of O2max in 45 min) twice a week with mild interval training (5×2 min of 85% of O2max interspersed by 3 minutes recovery) once a week on cycle ergometer among sixteen T2D males. Here, visceral adipose tissue as measured by magnetic resonance imaging was lowered by ~44%. Whole body mass was reduced by 1.9 kg corresponding to ~2%. In another study [74] comprising of interval training (4×4 min at 90% of HRmax interspersed by 3 minutes recovery at 70%) twice a week for 3 months on a treadmill among fifty-four class I obese adults, abdominal fat mass reduced by ~8% as measured by DXA-scans. Same group underwent measurement of waist circumference that was reduced with 7.2 cm (~7%). Additionally, using the same exercise protocol as Boudou et al., Mourier and colleagues [13] demonstrated that abdominal fat mass determined by means of Harpender skinfold caliper was lowered by 48% among twenty-four T2D patients. Same patient group reduced its waist circumference by 1 cm (1%). Even in overweight young males, 12 weeks of HIIT consisting of 8 sec. sprint (workload ~80–90% of HRmax) interspersed by 12 sec. recovery over 20 minutes reduced overall fat mass by 2.0 kg and abdominal fat mass by 0.14 kg [75]. From observational studies that have been comprehensively reviewed, there seems to be an anticipated inverse relationship between measures of fat mass and distribution and measures of physical exercise [76,77].

Although documentation is sparse in terms of the effect of HIIT on abdominal fat reduction among T2D populations, the magnitude of abdominal fat loss seems to be dependent on intensity. Thus, one research [17] has demonstrated that total and abdominal fat loss seems to be lowered more by HIIT than traditional continuous endurance training. Additionally, 15 weeks of 3 weekly sessions of HIIT on bicycle ergometer among diabetic obese women with polyneuropathy were found to be distinctly effective in lowering waist circumference, neuropathic pain, and hyperglycaemia as opposed to moderate intensity aerobic training [78].

The exact underlying mechanisms of the HIIT-induced abdominal fat loss are not investigated here. However, feasible explanations hereof may include excessive production of catecholamines, especially norepinephrine as opposed to continuous endurance training that typically results in relative small gains in catecholamines [79]. Particularly, the increased occurrence of β-adrenergic receptors in abdominal fat compared to subcutaneous fat indicates that HIIT may have a superior effect as opposed to continuous endurance training to drive lipolysis in abdominal fat stores [80] although greatest absolute change in fat mass in response to exercise will normally derive from subcutaneous adipose tissue [81]To our knowledge, fat oxidation experiments following a HIIT session have not been elucidated. However, given that an excessive fat oxidation occurs following HIIT, this could be explained by a broad range of factors, including the necessity of blood lactate and hydrogen ion removal for immediate glycogen resynthesis and/or elevated growth hormone levels [82,83]. Additionally, [83] an inhibition of anaerobic glycogenolysis appears, and adenosine triphosphate resynthesis is primarily derived from creatine phosphate degradation and intramuscular triacylglycerol stores. Interestingly, one study demonstrated that abdominal lipolysis in a T2D population is unaltered after exercise [84]In theory, exercise-induced abdominal fat mass reduction could be explained by the lowering of either adipocyte number and/or adipocyte size.

Study limitations

Here, we have demonstrated that T2D patients and matched controls are able to follow a controlled study with great compliance. Retrospectively, we could have considered conducting the different durations of the HIIT interventions. Additionally, almost every participant increased his/hers self-efficacy indicating that a pre-post survey favourably could be integrated in a future study. In this study, it was a logistical challenge to train the subjects during such intensive circumstances and in relation to equipment, which limited the number of participants. In light of the findings of the present study, we wish to conduct randomized studies in the future.


The study provides evidence for the health benefits of 8 weeks of HIIT in T2D patients. These effects of HIIT involved especially ameliorated glycaemic control and pancreatic β-cell function improving peripheral insulin action and reduced abdominal fat mass. In healthy subjects performing the same training, some, but not all, of the positive health effects of HIIT were observed. We observed some intrasubject heterogeneity in the exercise responsiveness in glycaemic control and pancreatic β-cell function. This indicates that more emphasis should be addressed for individualised specific needs together along with continued supervision of the oral hypoglycaemic treatment. Finally, more focus should be addressed on even more long-term HIIT interventions and/or the seemingly attenuated hyperglycaemic effects of resistance training.

Supporting Information

S1 Protocol. Trial protocol from the Ethical Committee translated.


S2 Protocol. Trial protocol to the Ethical Committee in Danish.



We acknowledge the following for technical, coordinating and statistical assistance: laboratory technicians E. M. Jensen and L. Trudsø Jensen. Coordinators at Vendsyssel Hospital, Hjørring C. B. Nielsen and B. B. Nielsen. Physiotherapist Luis Fernando Rodriges Perillo. M. Erlendsen for statistical help.

Author Contributions

Conceived and designed the experiments: PBJ SMM KO ACT. Performed the experiments: PBJ SMM ACT. Analyzed the data: PBJ SMM KO ACT. Contributed reagents/materials/analysis tools: PBJ SMM ACT. Wrote the paper: PBJ SMM KO ACT.


  1. 1. Unger RH. Glucagon physiology and pathophysiology. N Engl J Med 1971 Aug 19;285(8):443–449. pmid:4997492
  2. 2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997 Apr;20(4):537–544. pmid:9096977
  3. 3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 May 3;344(18):1343–1350. pmid:11333990
  4. 4. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003 Dec;26(12):3230–3236. pmid:14633807
  5. 5. American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013 Jan;36 Suppl 1:S11–66. pmid:23264422
  6. 6. Duncan GE, Anton SD, Sydeman SJ, Newton RL Jr, Corsica JA, Durning PE, et al. Prescribing exercise at varied levels of intensity and frequency: a randomized trial. Arch Intern Med 2005 Nov 14;165(20):2362–2369. pmid:16287765
  7. 7. Bjorntorp P, Fahlen M, Grimby G, Gustafson A, Holm J, Renstrom P, et al. Carbohydrate and lipid metabolism in middle-aged, physically well-trained men. Metabolism 1972 Nov;21(11):1037–1044. pmid:5080088
  8. 8. Shaban N, Kenno KA, Milne KJ. The effects of a 2 week modified high intensity interval training program on the homeostatic model of insulin resistance (HOMA-IR) in adults with type 2 diabetes. J Sports Med Phys Fitness 2014 Apr;54(2):203–209. pmid:24509992
  9. 9. Little JP, Gillen JB, Percival ME, Safdar A, Tarnopolsky MA, Punthakee Z, et al. Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl Physiol 2011 Dec;111(6):1554–1560. pmid:21868679
  10. 10. Karstoft K, Winding K, Knudsen SH, James NG, Scheel MM, Olesen J, et al. Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 2014 Oct;57(10):2081–2093. pmid:25099941
  11. 11. Slentz CA, Tanner CJ, Bateman LA, Durheim MT, Huffman KM, Houmard JA, et al. Effects of exercise training intensity on pancreatic beta-cell function. Diabetes Care 2009 Oct;32(10):1807–1811. pmid:19592624
  12. 12. Coker RH, Williams RH, Yeo SE, Kortebein PM, Bodenner DL, Kern PA, et al. The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity. J Clin Endocrinol Metab 2009 Nov;94(11):4258–4266. pmid:19808853
  13. 13. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP, et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 1997 Mar;20(3):385–391. pmid:9051392
  14. 14. Dengel DR, Galecki AT, Hagberg JM, Pratley RE. The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men. Am J Hypertens 1998 Dec;11(12):1405–1412. pmid:9880120
  15. 15. DiPietro L, Dziura J, Yeckel CW, Neufer PD. Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol (1985) 2006 Jan;100(1):142–149. pmid:16141382
  16. 16. Kang J, Robertson RJ, Hagberg JM, Kelley DE, Goss FL, DaSilva SG, et al. Effect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients. Diabetes Care 1996 Apr;19(4):341–349. pmid:8729157
  17. 17. Trapp EG, Chisholm DJ, Freund J, Boutcher SH. The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women. Int J Obes (Lond) 2008 Apr;32(4):684–691.
  18. 18. Helgerud J, Hoydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, et al. Aerobic high-intensity intervals improve VO2max more than moderate training. Med Sci Sports Exerc 2007 Apr;39(4):665–671. pmid:17414804
  19. 19. Slordahl SA, Madslien VO, Stoylen A, Kjos A, Helgerud J, Wisloff U. Atrioventricular plane displacement in untrained and trained females. Med Sci Sports Exerc 2004 Nov;36(11):1871–1875. pmid:15514500
  20. 20. Daussin FN, Zoll J, Dufour SP, Ponsot E, Lonsdorfer-Wolf E, Doutreleau S, et al. Effect of interval versus continuous training on cardiorespiratory and mitochondrial functions: relationship to aerobic performance improvements in sedentary subjects. Am J Physiol Regul Integr Comp Physiol 2008 Jul;295(1):R264–72. pmid:18417645
  21. 21. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006 Feb;16 Suppl 1:3–63. pmid:16451303
  22. 22. Assali AR, Ganor A, Beigel Y, Shafer Z, Hershcovici T, Fainaru M. Insulin resistance in obesity: body-weight or energy balance? J Endocrinol 2001 Nov;171(2):293–298. pmid:11691649
  23. 23. American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003 Jan 15;167(2):211–277. pmid:12524257
  24. 24. Hood MS, Little JP, Tarnopolsky MA, Myslik F, Gibala MJ. Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med Sci Sports Exerc 2011 Oct;43(10):1849–1856. pmid:21448086
  25. 25. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990 Jan 27;300(6719):230–235. pmid:2106931
  26. 26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul;28(7):412–419. pmid:3899825
  27. 27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 Sep;22(9):1462–1470. pmid:10480510
  28. 28. Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, Miyamoto S, et al. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr J 2012;59(1):55–64. pmid:22068110
  29. 29. Kim JY, Coletta DK, Mandarino LJ, Shaibi GQ. Glucose response curve and type 2 diabetes risk in Latino adolescents. Diabetes Care 2012 Sep;35(9):1925–1930. pmid:22751962
  30. 30. Croymans DM, Paparisto E, Lee MM, Brandt N, Le BK, Lohan D, et al. Resistance training improves indices of muscle insulin sensitivity and beta-cell function in overweight/obese, sedentary young men. J Appl Physiol (1985) 2013 Nov 1;115(9):1245–1253. pmid:23970530
  31. 31. Boule NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 2003 Aug;46(8):1071–1081. pmid:12856082
  32. 32. Solomon TP, Malin SK, Karstoft K, Kashyap SR, Haus JM, Kirwan JP. Pancreatic beta-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. J Clin Endocrinol Metab 2013 Oct;98(10):4176–4186. pmid:23966244
  33. 33. Eriksen L, Dahl-Petersen I, Haugaard SB, Dela F. Comparison of the effect of multiple short-duration with single long-duration exercise sessions on glucose homeostasis in type 2 diabetes mellitus. Diabetologia 2007 Nov;50(11):2245–2253. pmid:17763840
  34. 34. Rogers MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, Holloszy JO. Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 1988 Sep;11(8):613–618. pmid:3065001
  35. 35. Krotkiewski M, Lonnroth P, Mandroukas K, Wroblewski Z, Rebuffe-Scrive M, Holm G, et al. The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1985 Dec;28(12):881–890. pmid:3912243
  36. 36. Goedecke JH, Dave JA, Faulenbach MV, Utzschneider KM, Lambert EV, West S, et al. Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women. Diabetes Care 2009 May;32(5):860–865. pmid:19196884
  37. 37. Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 2010 Jul;33(7):1561–1566. pmid:20200305
  38. 38. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 2004 Nov;287(5):E1024–31. pmid:15251867
  39. 39. Solomon TP, Knudsen SH, Karstoft K, Winding K, Holst JJ, Pedersen BK. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity. J Clin Endocrinol Metab 2012 Dec;97(12):4682–4691. pmid:23043193
  40. 40. El-Assaad W, Joly E, Barbeau A, Sladek R, Buteau J, Maestre I, et al. Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832/13 ss-cells. Endocrinology 2010 Jul;151(7):3061–3073. pmid:20444946
  41. 41. Whyte LJ, Ferguson C, Wilson J, Scott RA, Gill JM. Effects of single bout of very high-intensity exercise on metabolic health biomarkers in overweight/obese sedentary men. Metabolism 2013 Feb;62(2):212–219. pmid:22999784
  42. 42. Whyte LJ, Gill JM, Cathcart AJ. Effect of 2 weeks of sprint interval training on health-related outcomes in sedentary overweight/obese men. Metabolism 2010 Oct;59(10):1421–1428. pmid:20153487
  43. 43. Babraj JA, Vollaard NB, Keast C, Guppy FM, Cottrell G, Timmons JA. Extremely short duration high intensity interval training substantially improves insulin action in young healthy males. BMC Endocr Disord 2009 Jan 28;9:3. pmid:19175906
  44. 44. Potteiger JA, Jacobsen DJ, Donnelly JE, Hill JO, Midwest Exercise Trial. Glucose and insulin responses following 16 months of exercise training in overweight adults: the Midwest Exercise Trial. Metabolism 2003 Sep;52(9):1175–1181. pmid:14506624
  45. 45. Mikus CR, Oberlin DJ, Libla J, Boyle LJ, Thyfault JP. Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes. Diabetologia 2012 May;55(5):1417–1423. pmid:22311420
  46. 46. Larsen S, Skaaby S, Helge JW, Dela F. Effects of exercise training on mitochondrial function in patients with type 2 diabetes. World J Diabetes 2014 Aug 15;5(4):482–492. pmid:25126394
  47. 47. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009 Jun 30;119(25):3244–3262. pmid:19506108
  48. 48. Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani AA. Effects of exercise on glucose tolerance and insulin resistance. Brief review and some preliminary results. Acta Med Scand Suppl 1986;711:55–65. pmid:3535414
  49. 49. Kjaer M, Hollenbeck CB, Frey-Hewitt B, Galbo H, Haskell W, Reaven GM. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. J Appl Physiol (1985) 1990 May;68(5):2067–2074. pmid:2193907
  50. 50. Gillen JB, Little JP, Punthakee Z, Tarnopolsky MA, Riddell MC, Gibala MJ. Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes. Diabetes Obes Metab 2012 Jun;14(6):575–577. pmid:22268455
  51. 51. Nelson RK, Horowitz JF. Acute exercise ameliorates differences in insulin resistance between physically active and sedentary overweight adults. Appl Physiol Nutr Metab 2014 Jul;39(7):811–818. pmid:24773370
  52. 52. Boule NG, Robert C, Bell GJ, Johnson ST, Bell RC, Lewanczuk RZ, et al. Metformin and exercise in type 2 diabetes: examining treatment modality interactions. Diabetes Care 2011 Jul;34(7):1469–1474. pmid:21602430
  53. 53. Lazarevic G, Antic S, Cvetkovic T, Vlahovic P, Tasic I, Stefanovic V. A physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with type 2 diabetes mellitus. Diabetes Metab 2006 Dec;32(6):583–590. pmid:17296511
  54. 54. Fritz T, Caidahl K, Krook A, Lundstrom P, Mashili F, Osler M, et al. Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance. Diabetes Metab Res Rev 2013 Jan;29(1):25–32. pmid:22887834
  55. 55. Gillen JB, Percival ME, Ludzki A, Tarnopolsky MA, Gibala MJ. Interval training in the fed or fasted state improves body composition and muscle oxidative capacity in overweight women. Obesity (Silver Spring) 2013 Nov;21(11):2249–2255.
  56. 56. Adamson S, Lorimer R, Cobley JN, Lloyd R, Babraj J. High intensity training improves health and physical function in middle aged adults. Biology (Basel) 2014 May 12;3(2):333–344.
  57. 57. Rynders CA, Weltman JY, Jiang B, Breton M, Patrie J, Barrett EJ, et al. Effects of exercise intensity on postprandial improvement in glucose disposal and insulin sensitivity in prediabetic adults. J Clin Endocrinol Metab 2014 Jan;99(1):220–228. pmid:24243632
  58. 58. Tessier D, Menard J, Fulop T, Ardilouze J, Roy M, Dubuc N, et al. Effects of aerobic physical exercise in the elderly with type 2 diabetes mellitus. Arch Gerontol Geriatr 2000 Oct 1;31(2):121–132. pmid:11090907
  59. 59. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984 May;26(5):355–360. pmid:6376244
  60. 60. Trovati M, Carta Q, Cavalot F, Vitali S, Banaudi C, Lucchina PG, et al. Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 1984 Sep-Oct;7(5):416–420. pmid:6389056
  61. 61. Castaneda C, Layne JE, Munoz-Orians L, Gordon PL, Walsmith J, Foldvari M, et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 2002 Dec;25(12):2335–2341. pmid:12453982
  62. 62. Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K, et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 2010 Nov 24;304(20):2253–2262. pmid:21098771
  63. 63. Marcus RL, Smith S, Morrell G, Addison O, Dibble LE, Wahoff-Stice D, et al. Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with type 2 diabetes mellitus. Phys Ther 2008 Nov;88(11):1345–1354. pmid:18801851
  64. 64. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004 Feb;53(2):294–305. pmid:14747278
  65. 65. Burgomaster KA, Heigenhauser GJ, Gibala MJ. Effect of short-term sprint interval training on human skeletal muscle carbohydrate metabolism during exercise and time-trial performance. J Appl Physiol 2006 Jun;100(6):2041–2047. pmid:16469933
  66. 66. Burgomaster KA, Hughes SC, Heigenhauser GJ, Bradwell SN, Gibala MJ. Six sessions of sprint interval training increases muscle oxidative potential and cycle endurance capacity in humans. J Appl Physiol 2005 Jun;98(6):1985–1990. pmid:15705728
  67. 67. Talanian JL, Galloway SD, Heigenhauser GJ, Bonen A, Spriet LL. Two weeks of high-intensity aerobic interval training increases the capacity for fat oxidation during exercise in women. J Appl Physiol (1985) 2007 Apr;102(4):1439–1447. pmid:17170203
  68. 68. Gibala MJ, Little JP, van Essen M, Wilkin GP, Burgomaster KA, Safdar A, et al. Short-term sprint interval versus traditional endurance training: similar initial adaptations in human skeletal muscle and exercise performance. J Physiol 2006 Sep 15;575(Pt 3):901–911. pmid:16825308
  69. 69. Lindsay FH, Hawley JA, Myburgh KH, Schomer HH, Noakes TD, Dennis SC. Improved athletic performance in highly trained cyclists after interval training. Med Sci Sports Exerc 1996 Nov;28(11):1427–1434. pmid:8933495
  70. 70. Laursen PB, Shing CM, Peake JM, Coombes JS, Jenkins DG. Interval training program optimization in highly trained endurance cyclists. Med Sci Sports Exerc 2002 Nov;34(11):1801–1807. pmid:12439086
  71. 71. Saltin B, Blomqvist G, Mitchell JH, Johnson RL Jr, Wildenthal K, Chapman CB. Response to exercise after bed rest and after training. Circulation 1968 Nov;38(5 Suppl):VII1–78. pmid:5696236
  72. 72. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990 Apr 7;335(8693):827–838. pmid:1969567
  73. 73. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier JF. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 2003 Nov;149(5):421–424. pmid:14585088
  74. 74. Tjonna AE, Stolen TO, Bye A, Volden M, Slordahl SA, Odegard R, et al. Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci (Lond) 2009 Feb;116(4):317–326.
  75. 75. Heydari M, Freund J, Boutcher SH. The effect of high-intensity intermittent exercise on body composition of overweight young males. J Obes 2012;2012:480467. pmid:22720138
  76. 76. Wareham N. Physical activity and obesity prevention. Obes Rev 2007 Mar;8 Suppl 1:109–114. pmid:17316312
  77. 77. Wareham NJ, van Sluijs EM, Ekelund U. Physical activity and obesity prevention: a review of the current evidence. Proc Nutr Soc 2005 May;64(2):229–247. pmid:15960868
  78. 78. Hamed NS, Raoof NALA. Effect of high intensity interval training on diabetic obese women with polyneuropathy: a randomized controlled clinical trial. Phys Ther Rehabil 2014;1(4).
  79. 79. Zouhal H, Jacob C, Delamarche P, Gratas-Delamarche A. Catecholamines and the effects of exercise, training and gender. Sports Med 2008;38(5):401–423. pmid:18416594
  80. 80. Rebuffe-Scrive M, Andersson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 1989 May;38(5):453–458. pmid:2725284
  81. 81. Schwartz RS, Shuman WP, Larson V, Cain KC, Fellingham GW, Beard JC, et al. The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism 1991 May;40(5):545–551. pmid:2023542
  82. 82. Nevill ME, Holmyard DJ, Hall GM, Allsop P, van Oosterhout A, Burrin JM, et al. Growth hormone responses to treadmill sprinting in sprint- and endurance-trained athletes. Eur J Appl Physiol Occup Physiol 1996;72(5–6):460–467. pmid:8925817
  83. 83. Trapp EG, Chisholm DJ, Boutcher SH. Metabolic response of trained and untrained women during high-intensity intermittent cycle exercise. Am J Physiol Regul Integr Comp Physiol 2007 Dec;293(6):R2370–5. pmid:17898114
  84. 84. Simonsen L, Henriksen O, Enevoldsen LH, Bulow J. The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects. Diabetologia 2004 Apr;47(4):652–659. pmid:15298342